Skip to content

Formycon AG Sustainability Reports

Formycon AG is an independent biotechnology company specializing in the development of high-quality biosimilars and follow-on biopharmaceutical medicines.

Sector: Professional & technical services

Country: Germany

Exchange: Deutsche Börse (Xetra)

ISIN: DE000A1EWVY8

11 reports from 2015 to 2025